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Humira, an anti-TNF drug aimed at decreasing inflammation in Rheumatoid Arthritis 
patients, can cause skin diseases from a rash to skin cancer. Humira works by blocking the 
chemical receptor RANKL, which therefore halts the production of osteoclasts, which attack and 
eat bone and cartilage, causing inflammation in arthritis patient’s joints. By analyzing Humira’s 
effect on the human body, it can be compared against other treatments such as electro-
acupuncture and pulsatile dry cupping to see if these alternative treatments can decrease 
inflammation in Rheumatoid Arthritis patients through blocking RANKL, and if they are safer 
methods for carrying out this treatment. Under close examination of scientific journals written on 
studies where patients and animals were treated with Humira, acupuncture, and cupping for 
inflammation due to arthritis, the data collected suggests that Humira, electro-acupuncture, and 
pulsatile dry cupping all decrease inflammation in the joints of Rheumatoid Arthritis patients. 
However, acupuncture patients overall have the least harmful side-effects, with nausea and 
localized tingling being the most common complaints. These outcomes are less life-altering than 
localized bruising from cupping or the consequences of Humira which include an increased risk 
of cancer, and heat and liver failure. Therefore, electro-acupuncture and pulsatile dry cupping 
should be used as a viable safer alternative to Humira in treatment of inflammation in 
Rheumatoid Arthritis patients. The data collected from this review is important because patients 
should know about less harmful alternative treatments, such as acupuncture, because it has been 
proven to have the same effects as Humira, but have less harmful consequences that will benefit 
the patient’s overall health. 
 
 




 With the United States becoming an international figure for politics, the world has also 
turned to follow its cultural and social norms. Currently, “pain is the second most common cause 
of loss of work in the United States, the common cold being ﬁrst” (Kim, 2004, p.135). 
Rheumatoid Arthritis (RA) is a form of arthritis that affects the joints, and is a common form of 
pain. These joints are normally paired joints that are found on both sides of the body, such as the 
wrists, hips, and knees. Currently, RA affects about 1% of the American population, and is more 
prevalent in women than in men. Inflammation in the joints is a symptom of RA, and is often 
associated with the pain in the joints that patients with RA feel.  
In order to treat the pain and inflammation from RA, there has been an incentive to 
develop new drugs that can take away this pain. Western medicine, which is based on the use of 
drugs  to treat symptoms of pain and discomfort, is highly valued by most medical doctors in the 
United States. This coincides with the need to cure different types of ‘pain’ because drugs can be 
made from new compounds that can treat different types of ‘pain’ in specific areas of the human 
body. With the United States being an international figure, and the ability of Western medicine 
to make drugs that can be applied to specific problems, the world has turned to drugs to solve all 
issues related to the body. However, according to Kim (2004), “with all the advances of 
technology and treatments, it [pain] still remains a major problem in our society and continues to 
worsen,” (p.135) proving that the increased use in drugs is not treating the ‘pain’ that Americans 
feel daily.  
 Thus, all treatment options must be considered when making a treatment plan for a 
patient. This includes using alternative medicine, as called in the United States, which is 
comprised of Traditional Chinese Medicine (TCM), a combination of “herbal remedies and 
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acupuncture are the treatments most commonly used by TCM practitioners,” (National Institute 
of Health, 2010, p.1) along with other forms of mind-body medicine that does not solely rely on 
drugs. Acupuncture, a form of TCM, has been practiced in China since before second century 
B.C., and has been used for centuries to cure pain. Today, “TCM is now practiced in one form or 
another by more than 300,000 practitioners in over 140 countries” (Scheid, 1999, p.10) and is 
taught in some European colleges, allowing TCM treatments to be available to many people 
throughout the United States , Europe, and Asia. Furthermore, new technology in combination 
with these TCM treatments has produced new forms of remedies that provide better results. 
These include electro-acupuncture, which provides an electric impulse to the needle while 
acupuncture is being performed, and pulsatile dry cupping, which “is a modernized technology 
using a mechanical device that generates a pulsatile vacuum with a pump,” (Teut et al., 2012, 
p.2). The ‘dry’ cupping refers to the skin not being cut where the cupping procedure is taking 
place. 
Inflammation in the joints, caused by RA, requires TNF reduction in order to treat this 
swelling. While the prescription drug Humira has high levels of TNF reduction, the side effects, 
especially “increased risk for developing serious infections that may lead to hospitalization or 
death” (Physician’s Desk Reference, 2012, p. 1), can lead to infections such as Tuberculosis and 
an increased risk for cancer. These adverse reactions make Humira less desirable then the 
alternative therapies of electro-acupuncture and pulsatile dry cupping  whose side-effects 
include, “nausea or small tingling pain where the needle was injected” (Ouyang, 2011, p.508), 
and localized bruising. Furthermore, Humira is the most expensive treatments to have for one 
year, and while it is the only medicine that can be delivered to your mailbox at your house, there 
is a growing number of facilities that offer acupuncture and cupping. Acupuncture is more 
Humira, Electro-Acupuncture, Pulsatile Dry Cupping on Rheumatoid Arthritis 5 
 
 
commonly found then cupping, being offered in every state, making electro-acupuncture the best 
choice for a patient who is looking to reduce their inflammation and pain due to Rheumatoid 
Arthritis.  
 
Inflammation Due To Rheumatoid Arthritis 
Rheumatoid Arthritis (RA) is a form of arthritis that affects joints that are found on both 
sides of the body, such as the wrists, hips, and knees. RA currently affects about 1% of the 
American population, and is more prevalent in women than in men. Women have a higher rate of 
RA due to a higher percentage of osteoporosis, which allows more bone damage to occur more 
quickly. Inflammation in the joints is a symptom of RA, and is often sought to be treated with 
drugs, acupuncture, and/or cupping. In order to treat RA, the process that causes inflammation 
has to first be analyzed and studied.  
According to G. Jie, a doctor at Suzhou Hospital of Traditional Medicine in China, et al. 
in their paper, Influence of electroacupuncture on tumor necrosis factor-α and vascular 
endothelial growth factor in rats with experimental arthritis, they state that “TNF-α [a form of 
TNF] is an important physiological mediator of inflammation that mediates the host 
inflammatory response and leads to tissue damage, and is one of the most active inflammatory 
factors in RA.” (2012, p.207) This is further supported in Effect of electro-acupuncture on tumor 
necrosis factor-α and vascular endothelial growth factor in peripheral blood and joint synovia of 
patients with rheumatoid arthritis, by Ouyang et al.(2011) in their study when they state: 
It is well-known that high levels of tumor necrosis factor-α (TNF-α) and vascular 
endothelial growth factor (VEGF) could be detected in blood serum or joint synovia of 
patients with rheumatoid arthritis (RA). (p.505)  
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This supports the fact that higher TNF levels are always found when there is an increase in 
inflammation. These findings show that TNF and inflammation have a directly proportional 
relationship to each other, and that any treatment to lower inflammation should also lower the 
TNF levels in the patient’s body.  
 In a study on how TNF is related to osteoclast production, Tumor necrosis factor 
receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts, Bai et al. 
(2008) reports that “RANK is a member of the tumor necrosis factor (TNF) receptor 
superfamily, and as such, its cytoplasmic domain binds a number of TNF receptor-associated 
factors (TRAFs)” (p.30861), meaning that because TNF and RANK have similar enough 
chemical structures they both activate RANKL, the cytoplasmic receptor of RANK. This is 
further proven to be accurate in, Changes in bone mineral density during long-term treatment 
with adalimumab in patients with rheumatoid arthritis: a cohort study, by Krieckaert et al. (2012) 
when they state: 
Generalized bone loss in osteoporosis goes beyond localized, periarticular bone loss in the 
affected joints. It is assumed that generalized and local bone loss share a common, 
inflammation-driven pathway, in which receptor activator of nuclear factor-B (RANKL) plays 
an important role. (p.1)  
Krieckaert et al. illustrate how TNF factors bind to RANKL to actively cause 
inflammation in the joints. This inflammation occurs when RANKL is activated, and causes the 
production of osteoclasts. These osteoclasts then attack the bones and cartilage, breaking up the 
organic bone located there, and causing inflammation as a result. Increasing TNF-α would 
“activate and damage the local vascular endothelial cells (VECs) to increase their permeability, 
and aggravate the local tissue inflammatory edema and infiltration” (Ouyang et al., 2011, p.505). 
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This research suggests that if TNF factors were to be lowered in the body, there would therefore 
be a decrease in osteoclast production, since RANKL would be activated in smaller amounts.  
Although the TNF pathway is focused in the research of this paper and how it lowers 
inflammation in RA patients, there is another chemical that produces a similar effect. Four and 
half LIM domain 2 (FHL2) also binds with RANKL, like TNF, except instead of activating 
RANKL, it inhibits it. This is explained as: 
Four and half LIM domain 2 (FHL2) is a LIM domain-only protein, not present in bone 
marrow macrophages (BMMs) but induced by RANKL, which binds TRAF6, thereby 
inhibiting its interaction with RANK (6). (Bai et al., 2008, p.30861) 
The inhibition of RANKL therefore stops the body’s production of osteoclasts thus leading to a 
stoppage of osteoclasts attacking and destroying the patient’s joints and a reduction in 
inflammation. Therefore, FHL2 and RANKL have an inverse relationship, with one increasing, 
while the other decreases. This means that in order to find a way to decrease inflammation 
through the RANKL pathway, either TNF factors must be reduced, or FHL2 factors must be 
increased. Either way will result in the decrease in the activation of RANKL, which will lead to a 
decrease in the amount of osteoclasts that are produced in the body.  
 
Prescription Drug Treatment of Rheumatoid Arthritis 
 When diagnosed with Rheumatoid Arthritis today, the most common form of treatment 
for the pain and inflammation associated with RA would be an anti-TNF drug, which would be 
prescribed by a doctor.  Currently, one of the most common drugs on the market is Humira, 
whose leading ingredient is the anti-TNF drug adalimumab. However, side effects of this drug 
range from “headache, stuffy nose, sinus pain, [and] mild stomach pain” (Physicians’ Desk 
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Reference, 2012, p.1), to a reduced immune system, which has caused some patients to have skin 
lesions, lymphoma, allergic reactions, and the inability to form blood clots. The Food and Drug 
Administration (FDA) warns on Humira’s prescription guidelines that “liver problems can 
happen in people who use TNF-blocker medicines. These problems can lead to liver failure and 
death” (2012, p.3196923). 
 Currently, according to the Physician’s Desk Reference (PDR) (2012), “Humira is 
indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the 
progression of structural damage, and improving physical function in adult patients with 
moderately to severely active rheumatoid arthritis” (p.1), and is used to treat RA’s inflammation 
and pain in the joints. It is proven in, TNF inhibiting therapy preferentially targets bone 
destruction but not synovial inflammation in a TNF driven model of rheumatoid arthritis, by 
Binder et al. (2012) that Humira works to lower the TNF that causes inflammation to occur 
because the inflammation is: 
Retarded, by treatment with the anti-TNF antibody infliximab, even if clinical signs and 
symptoms of inflammation are not affected. Similar observations have been also made 
for two other TNF inhibitors, etanercept and adalimumab [Humira] (p.611) 
Binder et al. findings are supported by their research that they conducted on the use of the anti-
TNF drug Humira, and how it affected the osteoclast (OC) numbers that are found in the body. 
This is relevant because when TNF activates RANKL, osteoclasts are produced in the bone, 
therefore when OC numbers decrease, TNF levels are being lowered. Binder et al. (2012) 
findings were as follows: 
We found that TNF inhibition dramatically reduced pre-OC numbers in a dose depended 
manner [figure 1, B]. Moreover, TNF inhibition was effective in reducing pre-OC 
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numbers not only in the absence, but even in the presence of RANKL [figure 2 D]. Taken 
together these data suggest that TNF inhibition mainly affects pre-OC differentiation 
rather than the development of mature OCs, at least under these conditions. (p.611)  
  
Figure 1 B: Use of different concentrations of Humira on pre-OC numbers. Figure 1 D: Effect of 
TNF inhibition of pre-OC numbers (Binder et al., 2012, p.611), 
Because TNF inhibitions only affect pre-OCs, it means that prior OC’s in the body will 
continue to be present and harm the joint. However, by using Humira, it will stop any new OC’s 
from forming, therefore over time, decreasing inflammation. When OC’s are formed, they attack 
the bone and cartilage in the joints. This leads to the bone mass density (BMD) to decrease in 
patients where OC’s are overactive, such as in Rheumatoid Arthritis patients. Therefore, 
Krieckaert’s et al. (2012) data that the “Mean BMD change per year was 0.58% and 0.07% for 
the hip and lumbar spine, respectively, during a mean follow-up period of 4 years,” (p.3) 
illustrates how the anti-TNF drug, Humira can help decrease the OC production, and therefore 
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Side-effects of Humira 
For all of the benefits that Humira can provide, it does have side-effects such as a 
decrease in immune system, an increased risk of cancer, and liver and heart failure, which can 
make Humira dangerous to take. Although all of these side-effects are not experienced by over 
50% of the patients that take Humira, the common side-effects that can effect day to day life 
include “headache, stuffy nose, sinus pain, mild stomach pain; or pain, redness, itching, swelling, 
or bleeding where you injected the medication” (Physician’s Desk Reference, 2012, p.1), and can 
still be crippling to the daily activities in a patient’s life. This is supported by the National 
Institute of Health (NIH) (2007) when they found that “common adverse reactions (incidence 
>10%): infections (e.g. upper respiratory, sinusitis), injection site reactions, headache and rash” 
(p. 1), are prevalent in patients. Although these reactions are not life threatening, they do cause 
the patient discomfort, and should be taken into consideration when taking Humira. The side-
effects that are life-threatening however, should not be taken lightly and should be considered 
before taking Humira, since it is more likely to happen in patients that are older and already have 
a serious infection such as Crohn’s disease, or heart disease. 
The most problematic of these effects are the decrease of the patient’s immune system. 
According to the Physician’s Desk Reference (PDR) (2012), “patients treated with Humira are at 
increased risk for developing serious infections that may lead to hospitalization or death” (p. 1), 
causing thousands of Humira patient’s to take other drugs to cure infections that they contract 
while on Humira. This risk of infection is supported because “serious infection…even if your TB 
test is negative your doctor should carefully monitor you for TB infections while you are taking 
HUMIRA” (Food and Drug Administration, 2012, p.3196923), illustrating how it becomes easier 
for a patient to contract tuberculosis while on Humira. The risk of serious infection is important 
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because many of the patients who are prescribed Humira are older, and already have a decreased 
immune system. This means that for these adults, with an even more compromised immune 
system, they can contract such diseases as “Tuberculosis (TB), invasive fungal, and other 
opportunistic infections, some fatal” (2007, p. 1), according to the National Institute of Health’s 
highlights of prescribing Humira information. These risks for infection for people who are taking 
Humira are also supported by the PDR (2012) and “active tuberculosis (TB), including 
reactivation of latent TB…Invasive fungal infections, including histoplasmosis, 
coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis… [and] 
bacterial, viral and other infections due to opportunistic pathogens, including Legionella and 
Listeria,” (p. 1) are repeatedly found in patients who are taking Humira.  
For the above mentioned diseases such as TB and fungal infections, these diseases 
present fairly quickly after taking Humira. However, Humira can cause cancer that may not 
become present until after the patient has stopped taking Humira. This is proven in a study, 
Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis, 
by Park (2012) that “TNF- blockers [including adalimumab/ Humira] used to treat inflammatory 
disorders are also believed to reduce host immune responses to malignancy, thereby indirectly 
increasing the risk of secondary cancers” (p.261).In Park’s study (2012), he found that “to date, 
data from several studies and case reports have shown an increased incidence of lymphoma in 
patients treated with anti-TNF agents” (p.259). These cases of lymphoma are supported by the 
NIH (2007) in their prescription data when they state, “Malignancies are seen more often than in 
controls, and lymphoma is seen more often than in the general population” (p. 1), and further 
supported by the FDA (2012) who found that besides lymphoma, other cancer such as “basal cell 
cancer and squamous cell cancer of the skin [occur in the patient]. These types of cancer are 
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generally not life-threatening if treated” (p. 3196923) but “people with RA, especially more 
serious RA, may have a higher chance for getting a kind of cancer called lymphoma” (p. 
3196923).  
 
Figure 2: Erthematous to brown nodules on the elbow and upper arm. (Park, 2012, 260) 
This is important because according to the PDR (2012) “Humira is indicated for reducing 
signs and symptoms, inducing major clinical response, inhibiting the progression of structural 
damage, and improving physical function in adult patients with moderately to severely active 
rheumatoid arthritis,” (p.1) and is therefore commonly prescribed to people with Rheumatoid 
Arthritis. This is important to note because having serious RA while on Humira directly 
“increases your change of having a higher chance for getting a kind of cancer called lymphoma” 
(Physician’s Desk Reference, 2012, p. 3196923). Furthermore: 
“Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell 
lymphoma, have been reported in patients treated with TNF blockers including Humira. 
These cases have had a very aggressive disease course and have been fatal” (Physician’s 
Desk Reference, 2012, p. 1) 
This means that by taking Humira, it is possible to contract strains of rare forms of lymphoma 
which can cause death because little knowledge is known about the cancer’s treatment and its 
inability to cure it.  
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Besides cancer, there are other side-effects that are prevalent with the use of Humira. The 
liver is an important organ in the body for its ability to clean the blood, regulate blood clots, and 
production of bile, and humans are unable to live without one. Therefore, it is a problem when 
the FDA (2012) finds that “liver problems can happen in people who use TNF-blocker medicines 
[Humira]. These problems can lead to liver failure and death” (p. 3196923), because by taking 
Humira, the patient is taking a drug that can harm the liver to a point where it can no longer 
function properly. Other problems that may occur include “heart failure, worsening or new onset, 
may occur” (National Institute of Health, 2007, p. 1), causing this drug to not be a choice option 
for those people who already have heart disease or who are at risk for heart attacks or heart 
disease.    
 Furthermore, Humira is expensive to buy, costing a patient with no insurance coverage 
around $4,507.36 a month because Humira is usually proscribed, “usually every other week” 
(Food and Drug Administration, 2012, p.1). However, after receiving a prescription from your 
doctor, Humira can be mailed to your home, or picked up at any local pharmacy, making it easily 
accessible to almost any person in the United States as long as they can pay for the dosages. This 
means that Humira should be used as a first choice of treatment only for patients who are house-
bound who cannot receive treatments, such as cupping or acupuncture, outside of their homes. 
Otherwise, the side-effects that can be caused by Humira should encourage the patient to first 
seek other options of treatment before taking Humira. 
 
How Electro-Acupuncture Works 
 Electro-acupuncture is effective at reducing inflammation caused by Rheumatoid 
Arthritis because electro-acupuncture targets the TNF levels in the peripheral blood as well as 
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the TNF in the joint fluid. This results in electro-acupuncture successfully lowering TNF levels 
in the body, and causing the decrease of inflammation in the patient’s joints. The side-effects of 
electro-acupuncture are minimal, and include nausea, and mild swelling, bruising, and bleeding 
at the site of needle insertion.  
 Acupuncture has been used to treat pain and inflammation in people since second century 
B.C.E. In, Influence of electroacupuncture on tumor necrosis factor-α and vascular endothelial growth 
factor in rats with experimental arthritis, Jie et al. (2012) found that: 
Due to the universality and network profile of the cytokines in the pathological process of RA, 
the pathway for EA [electro-acupuncture] effect on TNF-α and VEGF reduction might be as 
the following four: the first is a direct inhibitory effect; the second is indirect inhibition, i.e., 
through the cytokines mutual coupling effect; the third is the role of chemokine generation; 
the last is the regulatory function of nerve-immune-endocrine system. (p.208) 
Jie et al. suggest that EA has a direct effect on the amount of TNF in the body.  Jie et al.(2012) claim 
is supported by his results in his trial which showed that “synovial content were insignificantly 
different after treatment (P>0.05), suggesting the equivalent effects of EA and SN in lowering TNF-α 
contents” (p.3).  
 
Table 1: Comparison of TNF-α Contents in Blood and Synovia. (Ouyang, 2011, p.507) 
Because TNF factors were lowered due to EA, it means that less RANKL was activated, and caused a 
decrease in osteoclast production. This would lead to a decrease in inflammation, which was proven 
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by a “reduction of stimulation caused by antigen in the whole body and local inflammation” (Jie et al., 
2012, p. 207). 
 Furthermore, in Effect of electro-acupuncture on tumor necrosis factor-α and vascular 
endothelial growth factor in peripheral blood and joint synovia of patients with rheumatoid arthritis, 
Ouyang et al. (2011) described their patients as having “high acceptance” (p.508) referring to the fact 
that their patients had no or minimal discomfort with electro-acupuncture, and therefore did not stop 
treatment. “High acceptance” is important because as a viable treatment for inflammation, EA must 
be used on as many different types of people with different diseases and pain tolerance levels. This 
discomfort consisted of nausea or small tingling pain where the needle was injected. They also 
observed that there were not any “adverse reaction related with the treatment [that] occurred during 
the observation period” (Ouyang et al., 2011, p.508), concluding that no allergic reactions or major 
health issues occurred. The one caveat to electro-acupuncture is that blood diseases could be passed 
between people who shared needles. Therefore, when receiving electro-acupuncture, it should be done 
in a medical facility that uses safe disposal and cleaning methods for objects that have body fluids on 
them. 
 In terms of cost, the amount of money per week for acupuncture is drastically lower than 
paying for Humira, with “sessions with an acupuncturist running about $65 to $120, depending 
on where you live” (Alderman, 2010, p.B5). With even the most expensive treatments costing 
$300 a session cost only $3600 a year; it is still about $1,000 less than Humira treatment. 
However, many “acupuncture schools have clinics where you can be treated by supervised 
students at discounted rates of $40 or so for one to two hours” (Alderman, 2010, p.B5), which 
would decrease the costs of having acupuncture performed. These schools are located within 
every state of the United States, including some territories, and most offer reduced prices when 
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students are performing the acupuncture. Therefore, if the patient has a car, or has access to 
public transportation, it is more likely that he or she can find a school that is sponsored by the 
American Association of Acupuncture and Oriental Medicine. There, they can receive cheaper 
acupuncture treatment, and therefore acupuncture should be considered as a treatment when 
compared to the prescription drug Humira. 
 
How pulsatile dry cupping works 
 Pulsatile dry cupping is one way to treat Rheumatoid Arthritis patients because it can 
stimulate deep into the skin, and affect the acupuncture points, that will lead to a release of 
chemicals in the body which will decrease the levels of TNF. This will result in a decrease of 
inflammation in the joints with bruising and swelling around the site where cupping has 
occurred.  
 Cupping can come in two different forms, dry and wet cupping, according to M. Teut et 
al. in, Pulsatile dry cupping in patients with osteoarthritis of the knee – a randomized controlled 
exploratory trial. Today, the most common form, and the one that Teut et al. used in their studies, 
is pulsatile dry cupping. Pulsatile dry cupping “is a modernized technology using a mechanical 
device that generates a pulsatile vacuum with a pump,” (Teut et al., 2012, p.2) when the vacuum 
is applied to the area that has pain with a cup.  
 
Figure 3: Application of adaptable silicone cup at the knee. (Teut et al., 2012, p.4) 
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By using modeling in, Cupping: From a biomechanical perspective, Tham et al. (2005) 
found that the stresses on the skin are caused by the pulsatile dry cupping was found at the: 
The center of the cup (r ¼ 0 mm) and the compressive stresses just beyond the rim of the cup 
ðrX25 mmÞ are increased for increasing vacuum pressure loads. For the vacuum pressures 
applied, the results also show that the effect of cupping does not extend beyond the area 
enclosed by the cup; at twice the cup diameter ðr ¼ 50 mmÞ, the stresses at the fat-muscle 
interface are negligible. (p.2188)  
This pressure is what will ultimately cause the decrease in inflammation in their affected joints that 
the cupping is being applied to. Teut et al. (2012) postulates that “the level of the spinal cord may also 
be involved [in reduction of pain]: Manipulations may stimulate inhibitory receptive fields of the 
multi-receptive dorsal horn neurons” (p.8). This theory is further supported by Tham (2005), because 
according to his theory: 
AA (Acupuncture analgesia) is initiated by the stimulation of the small diameter nerves in 
muscles which then send impulses to the spinal cord. The three neural centers, namely, the 
spinal cord, the mid-brain, and the pituitary are subsequently activated and release transmitter 
chemicals, such as endorphins and monoamines, which block the pain messages.” (p.2184) 
With the spinal cord actively engaged by cupping, this could account for natural chemicals being 
released by the brain which act like anesthesia to stop pain being felt in the area that the cupping is 
being done. These chemicals could also act like FHL2, and act as a blockage to the stimulation of 
RANKL. This would stop the formation of osteocytes, which would then lead to the decrease in 
inflammation in the patient’s body. 
 While cupping does decrease pain and inflammation overall in the area that the cup is being 
applied to, cupping of all types causes some damage to skin. Cupping “may firstly influence chronic 
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pain locally by deforming or even injuring the skin which stimulates Aβ fibers in painful but also 
distal skin regions,” (Teut et al., 2012, p.8). This damage to the skin is primarily seen and 
characterized by Tham (2205) as: 
Ecchymosis, a discolouration of the skin caused by the escape of blood into the tissue from 
ruptured blood vessels. This is a characteristic feature of the cupping treatment and takes the 
form of a circular lesion” (p.2192). 
 
Figure 4: Results of Cupping (Tham et al., 2005, p.2191) 
However, while pulsatile dry cupping can cause some skin discomfort through bruising, cupping has 
one major advantage in that “transmission of blood-borne diseases can be avoided since skin is not 
penetrated” (Tham et al, 2005, p.2191). This makes cupping superior to acupuncture and Humira, 
because in both of these alternatives, a needle must puncture the skin, in order to stimulate the 
acupuncture point, and in Humira’s case, inject the medicine into the patient. Pulsatile dry cupping 
though can stimulate these acupuncture points without puncturing the skin. 
Cupping, like acupuncture, is less expensive than the cost of prescription Humira. 
Cupping tends to run between “£40[$52.40] to £50 [$65.50] a session–lasting from half an hour 
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to 40 minutes. The number of sessions needed is determined by the therapist” (British 
Acupuncture Council, 200, p.1), which would equate to around $786 per year, making cupping 
the cheapest of the three treatments. However, cupping is the hardest of the three options to 
obtain because it is not wide spread across the United States, with only one location in some 
states. However, due to its low cost and only side effect of bruising, pulsatile dry cupping should 
be seen as an alternative to Humira. 
 
Conclusion 
From the evidence that is gathered, it is illustrated that Humira, electro-acupuncture, and 
pulsatile dry cupping all decrease the levels of TNF in the human body. This reduction in TNF 
leads to a less osteoclast formation, and therefore a minimization of swelling in patient with 
Rheumatoid Arthritis. However, due to the side-effects of these drugs, they should not all be 
considered equal relative to patient health. 
When looking at the costs and location of these three treatments, Humira and acupuncture 
are the most expensive and therefore pulsatile dry cupping should be the patient’s first option. 
The only caveat to this is that cupping is the hardest form of treatment to find in the United 
States. If the patient is house bound, Humira should be used. Otherwise, acupuncture would be 
the easiest to find, and is the second cheapest option of treatment. 
When looking solely at the patient’s health, Humira should be the last remedy to be used 
to try and treat the symptoms of RA. While Humira has been proven to lower TNF factors and 
help many people with inflammation associated to their Rheumatoid Arthritis, the side-effects 
can be life-threatening and definitely life-altering. Any drug that is “believed to reduce host 
immune responses to malignancy, thereby indirectly increasing the risk of secondary cancers” 
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(Park, 2012, p.261), should not be used for the general public. One might argue that this is 
considered an ‘uncommon’ side-effect, and therefore Humira should still be taken. However, 
“headache, stuffy nose, sinus pain, mild stomach pain” (Physician’s Desk Reference, 2012, p.1), 
are common in patients who take Humira, and can affect the patient’s happiness, and day to day 
life routines. Furthermore, any drug that ‘reduces host immune responses’ and will give RA 
patients a “higher chance for getting a kind of cancer called lymphoma” (Food and Drug 
Administration, 2012, p. 3196923) can cause side-effects that may not appear until after the 
patient has stopped taking Humira and many years have passed.  
Therefore the two best options in term of health for the patient are pulsatile dry cupping 
and electro-acupuncture. This is because while pulsatile dry cupping my cause, “ecchymosis, a 
discolouration of the skin caused by the escape of blood into the tissue from ruptured blood 
vessels” (Tham, 2005, p.2192), and electro-acupuncture can cause “discomfort consisted of 
nausea or small tingling pain where the needle was injected” (Ouyang, 2011, p.508), these are 
byproduct that will last only a few weeks at the most. Pulsatile dry cupping may be better than 
electro-acupuncture because there is a small chance of contracting a blood disease from electro-
acupuncture because the doctor that administers the treatment must pierce the skin in order to 
perform the treatment, where in pulsatile dry cupping, the skin in never broken. 
 In conclusion, Humira has the worst side-effects, and also costs the most per month, 
therefore making it the least desirable option of treatment. The safer alternatives would be to use 
electro-acupuncture or cupping. Both of these drugs cost less than Humira per month, and are 
safer because they do not cause any long term side-effects. However, of the two, cupping is 
harder to find in the United States, making acupuncture the finest option of treatment.  
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